CEO SUMMARY: A new report from the Office of Inspector General sheds interesting light on just how much genetic testing has increased among Medicare Part B beneficiaries. With billions of dollars in reimbursement at stake for clinical laboratories, expect federal officials to examine the medical necessity of these tests, warns healthcare attorney Alissa D. Fleming. […]
Clinical Labs Must Prep for Heightened Audits
OIG says genetic testing accounts for $3.6 billion in Medicare spending, which may bring scrutiny
- By Janette Wider
- > From the Volume XXXIII, No. 3 - March 2, 2026 Issue
- Tags: Alissa D. Fleming, Baker Donelson Bearman Caldwell and Berkowitz PC, clfs, Clinical Laboratory Fee Schedule, cpt code, Department of Health and Human Services, Fee-for-service, genetic testing, HHS, internal audits, lab risk & compliance, Medicare Advantage, Medicare Part A, Medicare Part B, Office of Inspector General, OIG, OIG audits, PAMA, pcr testing, Protecting Access to Medicare Act, Reimbursement, Unified Program Integrity Contractor
